Office of Research and Technology Management’s Joseph Jankowski discusses timeline for drug developments to be seen at patient level

UA spinoff creating 3-D cell models for cancer research

Crain’s Cleveland BusinessJoseph Jankowski, chief innovation officer in the Office of Research and Technology Management, discussed how there can be a long turnaround in seeing an advance in drug development being implemented for patients.